shadow_tr

EXPLORE

Primary Research Programs

Cross-Programmatic Focus Groups

  • Circadian Cancer Biology Group
  • Cancer Health Disparities
  • Cancer Biology
  • Translational Research & Therapeutics
  • Prostate Cancer
  • Breast Cancer
  • Leukemia/Lymphoma
  • Gynecologic Cancers

 

 

Tumor Biology & Signaling

Normal cells have a complex series of molecular signals that allow communication between cells as well as transmittal of signals to the cell nucleus. These signals are critical for regulating cell growth, apoptosis, angiogenesis and immune avoidance of the tumor. Changes in the signaling pathways, either through mutation or changes in gene expression, are necessary for tumor growth. These aberrant signaling pathways, both in the tumor and in normal tissues, represent ideal targets for therapeutic intervention in translational cancer research.

Tulane Cancer Center Program Faculty Members in Clinical and Translational Research Program Include….

 

Asim Abdel-Mageed, DVM, Ph.D.
Vecihi Batuman, M.D.
Aline Betancourt, Ph.D.
David Blask, M.D., Ph.D.
Matthew Burow, Ph.D.
Bridgette Collins-Burow, M.D., Ph.D.
David Coy, Ph.D.
Srikanta Dash, Ph.D.
Yan Dong, Ph.D.
Samir El-Dahr, Ph.D.
David Franklin, Ph.D.
Chang Han, M.D., Ph.D.
Steven Hill, PH.D. – Program Leader

S. Michal Jazwinski, Ph.D.
Joseph Lasky, M.D.
John McLachlan, Ph.D.
Charles Miller, III, Ph.D.
Cindy Morris, Ph.D.
Brian Rowan, Ph.D.
Gabriele Sabbioni, Ph.D.
Oliver Sartor, M.D.
Deborah Sullivan, Ph.D.
William Wimley, Ph.D.
Tong Wu, M.D., Ph.D.
Zongbing You, M.D., Ph.D.
Haitao Zhang, Ph.D.

 

1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu